Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

SCH-442,416

From Wikipedia, the free encyclopedia

SCH-442,416
Names
Preferred IUPAC name
2-(Furan-2-yl)-7-[3-(4-methoxyphenyl)propyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
Other names
SCH-442,416
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C20H19N7O2/c1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18/h3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24) checkY
    Key: AEULVFLPCJOBCE-UHFFFAOYSA-N checkY
  • InChI=1/C20H19N7O2/c1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18/h3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24)
    Key: AEULVFLPCJOBCE-UHFFFAOYAA
  • n1n3c(nc4c(c3nc1c2occc2)cnn4CCCc5ccc(OC)cc5)N
Properties
C20H19N7O2
Molar mass389.410
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

SCH-442,416 is a highly selectiveadenosineA2a subtype receptorantagonist. It is widely used in its11Cradiolabelled form to map the distribution of A2a receptors in the brain, where they are mainly found in thestriatum,nucleus accumbens, andolfactory tubercle.[1] Given its distribution in the brain, A2a receptors have been investigated for the treatment of various neurological disorders, and SCH-442,416 has shown promise in treatment ofdepression,[2]Parkinson's disease,[3] andcatalepsy.[4]

References

[edit]
  1. ^Moresco RM, Todde S, Belloli S, Simonelli P, Panzacchi A, Rigamonti M, et al. (April 2005). "In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416".European Journal of Nuclear Medicine and Molecular Imaging.32 (4):405–13.doi:10.1007/s00259-004-1688-5.PMID 15549298.S2CID 20909406.
  2. ^El Yacoubi M, Costentin J, Vaugeois JM (December 2003). "Adenosine A2A receptors and depression".Neurology.61 (11 Suppl 6): S82-7.doi:10.1212/01.wnl.0000095220.87550.f6.PMID 14663017.S2CID 36219448.
  3. ^Matsuya T, Takuma K, Sato K, Asai M, Murakami Y, Miyoshi S, et al. (March 2007)."Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model".Journal of Pharmacological Sciences.103 (3):329–32.doi:10.1254/jphs.scz070058.PMID 17341841.
  4. ^Mihara T, Noda A, Arai H, Mihara K, Iwashita A, Murakami Y, et al. (July 2008)."Brain adenosine A2A receptor occupancy by a novel A1/A2A receptor antagonist, ASP5854, in rhesus monkeys: relationship to anticataleptic effect".Journal of Nuclear Medicine.49 (7):1183–8.doi:10.2967/jnumed.108.051474.PMID 18552135.

External links

[edit]
Receptor
(ligands)
P0 (adenine)
P1
(adenosine)
P2
(nucleotide)
P2X
(ATPTooltip Adenosine triphosphate)
P2Y
Transporter
(blockers)
CNTsTooltip Concentrative nucleoside transporters
ENTsTooltip Equilibrative nucleoside transporters
PMATTooltip Plasma membrane monoamine transporter
Enzyme
(inhibitors)
XOTooltip Xanthine oxidase
Others
Others
Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=SCH-442,416&oldid=1330495947"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp